A leading Pioneer in sequencing, genotyping and bioinformatics since 2001, GenoScreen develops innovation programs that fuel its technological lead and drive the development of innovative products such as Deeplex® Myc-TB, the comprehensive test for simultaneous prediction of (hetero)resistance to 15 anti-tuberculosis drugs, MTBC genotyping and mycobacterial identification. Based on Next Generation Sequencing, this innovative kit is already CE-IVD marked and used in more than 35 countries. 

With GenoScreen, discover:

• Cutting-edge services in genomics, metagenomics and bioinformatics

GenoScreen offers a wide range of solutions based on 20 years of experience and on a technological platform benefiting from the most powerful equipment.

• A key player in molecular microbiology research and innovation

Involved in a wide range of research programs and projects, both public and private, GenoScreen develops a portfolio of analysis and control tools in genomics, metagenomics and molecular microbiology.

• A company at the service of Humankind and its environment

The services and innovations developed by GenoScreen aim to meet the needs of academic and industrial researchers and health care professionals facing various problems in the health care of humans, animals, plants and the environment sectors.

http://www.genoscreen.com/  https://www.deeplex.com/